RBC Downgrades Chemours to Sector Perform From Outperform, Cuts Price Target to $14 From $22
Oct 13, 2026
RBC Capital Markets downgraded Chemours to Sector Perform and lowered its price target to $14 from $22 due to a revised outlook. The company currently retains an average overweight rating with a mean price target of $17.64.
Show all 136 updates